外科用羊膜市場規模、佔有率和成長分析：按產品類型、產品形式、應用、最終用戶、原料、分銷管道和地區分類－2026-2033年產業預測

2024 年全球外科羊膜市場價值為 32.6 億美元，預計到 2025 年將成長至 38.7 億美元，到 2033 年將成長至 152.6 億美元，在預測期（2026-2033 年）內複合年成長率為 18.7%。

全球外科羊膜市場是指從人類羊膜中提取的醫療產品，用於傷口縫合、眼部重組和組織再生。由於羊膜具有抗發炎和抗菌等天然特性，能夠促進術後恢復並減少併發症，該市場正在不斷擴張。微創手術的需求日益成長，而快速恢復是其首要目標，這促使醫院傾向於選擇生物來源的替代材料而非人工縫合線。羊膜在再生眼科領域的應用不斷擴展，成為成長要素。在再生眼科領域，羊膜被用於治療與老齡化相關的眼科疾病並改善視力維持。此外，歐洲和北美地區優惠的保險報銷政策使這些治療更具成本效益，而凍乾即用型產品的持續研發也為供應商創造了更多市場機會。

全球外科用羊膜市場的成長要素

重組手術和創傷治療治療的日益普及顯著提升了對生物活性敷料的需求。醫療專業人員越來越認知到羊膜的益處，羊膜含有天然生長因子和抗發炎成分，能夠促進組織再生。這種日益成長的認知促使醫院將羊膜產品納入治療方案，從而擴展了其臨床應用。因此，隨著醫療機構尋求更有效的方法來改善患者預後，這些創新羊膜解決方案的應用也不斷擴展，最終推動了全球外科羊膜市場的成長。

全球外科羊膜市場的限制因素

羊膜製品的生產涉及複雜的製造程序，需要對捐贈者進行嚴格的篩檢、遵循嚴格的無菌技術以及滿足特定的儲存條件，所有這些都增加了生產成本。因此，醫院和診所需要投入大量資金來獲取這些生物敷料，加重了患者的治療負擔。如果缺乏針對這些昂貴手術的合理報銷政策，醫療機構可能會限制羊膜的使用，從而限制患者獲得這些先進治療方案的機會。因此，這些財務和程序方面的挑戰嚴重限制了全球外科用羊膜市場的成長。

全球外科羊膜市場趨勢

隨著醫療機構將再生醫學融入外科手術實踐，全球外科用羊膜市場正經歷顯著成長。羊膜富含天然生長因子和抗發炎成分，能夠顯著促進組織癒合，改善術後效果，因此其應用日益廣泛。這一趨勢在整形外科、眼科和創傷護理手術中尤其明顯，併發症的減少帶來了更好的治療效果。因此，醫療機構越來越重視建立高效率的羊膜採購和庫存管理流程，以滿足再生醫學領域日益成長的需求，並確保穩定的供應。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球外科用羊膜市場規模：依產品類型分類

• 羊膜
• 羊水製品
• 複合羊膜移植
• 其他

全球外科用羊膜市場規模：依產品類型分類

• 冷凍保存
• 脫水
• 冷凍乾燥

全球外科用羊膜市場規模：依應用領域分類

• 眼科
• 整形外科
• 創傷護理
• 其他

全球外科用羊膜市場規模：依最終用戶分類

• 醫院
• 門診手術中心
• 專科診所
• 其他

全球外科用羊膜市場規模：依原料分類

• 人類羊膜
• 人類羊水

全球外科用羊膜市場規模：依分銷管道分類

• 直銷
• 醫療批發商
• 其他

全球外科用羊膜市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• MiMedx Group, Inc.
• Organogenesis Holdings Inc.
• Integra LifeSciences Holdings Corporation
• Stryker Corporation
• Smith & Nephew plc
• Applied Biologics LLC
• Skye Biologics
• Amnio Technology, LLC
• BioLab Sciences
• Vivex Biologics, Inc.
• LifeNet Health
• AlloSource
• Celularity Inc.
• TissueTech, Inc.
• MTF Biologics
• Surgenex LLC
• Next Biosciences
• Katena Products, Inc.
• Merakris Therapeutics
• Arthrex, Inc.

結論與建議

Global Surgical Amniotics Market size was valued at USD 3.26 Billion in 2024 and is poised to grow from USD 3.87 Billion in 2025 to USD 15.26 Billion by 2033, growing at a CAGR of 18.7% during the forecast period (2026-2033).

The global surgical amniotics market is defined by medical products derived from human amniotic membranes, utilized in wound closure, ocular reconstruction, and tissue regeneration. The market thrives due to the membranes' natural properties, such as anti-inflammatory and antimicrobial effects, aiding in postoperative recovery and reducing complications. The rising demand for minimally invasive surgeries, focusing on rapid recovery, drives hospitals to favor biological substitutes over artificial sutures. A significant growth driver is the increased application of amniotic membranes in regenerative ophthalmology, where they address age-related eye diseases and enhance vision preservation. Moreover, favorable reimbursement systems in Europe and North America recognize these treatments as cost-effective, and ongoing research and development into lyophilized, ready-to-use products create additional market opportunities for suppliers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Surgical Amniotics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Surgical Amniotics Market Segments Analysis

Global surgical amniotics market is segmented by product type, product form, application, end user, source, distribution channel and region. Based on product type, the market is segmented into Amniotic Membranes, Amniotic Fluid Products, Composite Amniotic Grafts and Others. Based on product form, the market is segmented into Cryopreserved, Dehydrated and Lyophilized. Based on application, the market is segmented into Ophthalmology, Orthopedics, Wound Care and Others. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others. Based on source, the market is segmented into Human Amniotic Membrane and Human Amniotic Fluid. Based on distribution channel, the market is segmented into Direct Sales, Medical Distributors, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Surgical Amniotics Market

The growing prevalence of reconstructive surgeries and procedures focused on wound healing has significantly heightened the demand for biologically active dressings. Healthcare practitioners increasingly recognize the benefits of amniotic membranes, which contain natural growth factors and anti-inflammatory properties that facilitate faster tissue regeneration. This realization has prompted hospitals to incorporate amniotic products into their treatment protocols, thereby broadening their application in clinical settings. As a result, the adoption of these innovative amniotic solutions is expanding, ultimately driving the growth of the Global Surgical Amniotics market as healthcare providers seek more effective ways to enhance patient outcomes.

Restraints in the Global Surgical Amniotics Market

The production of amniotic membrane products involves complex manufacturing processes that require thorough donor screening, stringent aseptic techniques, and specific storage conditions, all of which contribute to higher production costs. This necessitates significant financial investment from hospitals and clinics to obtain these biological dressings, leading to increased expenses for patients seeking treatment. In the absence of adequate reimbursement policies for these costly procedures, healthcare providers may restrict the usage of amniotic membranes, thereby limiting patient access to these advanced therapeutic options. Consequently, these financial and procedural challenges pose significant constraints on the growth of the global surgical amniotics market.

Market Trends of the Global Surgical Amniotics Market

The Global Surgical Amniotics market is experiencing notable growth as healthcare providers integrate regenerative therapies into surgical practices. The utilization of amniotic membranes is gaining traction due to their rich natural growth factors and anti-inflammatory properties, which significantly enhance tissue healing and improve postoperative outcomes. This trend is particularly prevalent in orthopedic, ophthalmic, and wound care surgeries, where reduced complications are leading to more favorable results. Consequently, medical institutions are increasingly focused on establishing efficient protocols for sourcing and managing amniotic membrane inventory, ensuring they have a consistent supply to meet the rising demand in regenerative surgical applications.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Surgical Amniotics Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Amniotic Membranes
• Amniotic Fluid Products
• Composite Amniotic Grafts
• Others

Global Surgical Amniotics Market Size by Product Form & CAGR (2026-2033)

• Market Overview
• Cryopreserved
• Dehydrated
• Lyophilized

Global Surgical Amniotics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Ophthalmology
• Orthopedics
• Wound Care
• Others

Global Surgical Amniotics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Global Surgical Amniotics Market Size by Source & CAGR (2026-2033)

• Market Overview
• Human Amniotic Membrane
• Human Amniotic Fluid

Global Surgical Amniotics Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Medical Distributors
• Others

Global Surgical Amniotics Market Size & CAGR (2026-2033)

• North America (Product Type, Product Form, Application, End User, Source, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Product Form, Application, End User, Source, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Product Form, Application, End User, Source, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Product Form, Application, End User, Source, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Product Form, Application, End User, Source, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• MiMedx Group, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organogenesis Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied Biologics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Skye Biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amnio Technology, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLab Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivex Biologics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeNet Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AlloSource
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celularity Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TissueTech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MTF Biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surgenex LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Next Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Katena Products, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merakris Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations